Distinct Mechanisms of Pathogenic DJ-1 Mutations in Mitochondrial Quality Control

The deglycase and chaperone protein DJ-1 is pivotal for cellular oxidative stress responses and mitochondrial quality control. Mutations in PARK7, encoding DJ-1, are associated with early-onset familial Parkinson’s disease and lead to pathological oxidative stress and/or disrupted protein degradation by the proteasome. The aim of this study was to gain insights into the pathogenic mechanisms of selected DJ-1 missense mutations, by characterizing protein–protein interactions, core parameters of mitochondrial function, quality control regulation via autophagy, and cellular death following dopamine accumulation. We report that the DJ-1M26I mutant influences DJ-1 interactions with SUMO-1, in turn enhancing removal of mitochondria and conferring increased cellular susceptibility to dopamine toxicity. By contrast, the DJ-1D149A mutant does not influence mitophagy, but instead impairs Ca2+ dynamics and free radical homeostasis by disrupting DJ-1 interactions with a mitochondrial accessory protein known as DJ-1-binding protein (DJBP/EFCAB6). Thus, individual DJ-1 mutations have different effects on mitochondrial function and quality control, implying mutation-specific pathomechanisms converging on impaired mitochondrial homeostasis.

[1]  M. Martínez-Vicente Neuronal Mitophagy in Neurodegenerative Diseases , 2017, Front. Mol. Neurosci..

[2]  G. Wells,et al.  The pharmacological regulation of cellular mitophagy. , 2017, Nature chemical biology.

[3]  M. Campanella,et al.  Molecular Biology Digest of Cell Mitophagy. , 2017, International review of cell and molecular biology.

[4]  Daniel A East,et al.  Mitophagy and the therapeutic clearance of damaged mitochondria for neuroprotection. , 2016, The international journal of biochemistry & cell biology.

[5]  M. Sharon,et al.  Structural Characterization of Missense Mutations Using High Resolution Mass Spectrometry: A Case Study of the Parkinson’s-Related Protein, DJ-1 , 2016, Journal of The American Society for Mass Spectrometry.

[6]  M. Sharon,et al.  The Parkinson’s-associated protein DJ-1 regulates the 20S proteasome , 2015, Nature Communications.

[7]  Daniel A East,et al.  TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control , 2014, Autophagy.

[8]  G. Halliday,et al.  Alpha-synuclein biology in Lewy body diseases , 2014, Alzheimer's Research & Therapy.

[9]  David S. Park,et al.  DJ-1 Interacts with and Regulates Paraoxonase-2, an Enzyme Critical for Neuronal Survival in Response to Oxidative Stress , 2014, PloS one.

[10]  J. Wilczyński,et al.  Mitochondrial dysfunction in cancer , 2014, Przeglad menopauzalny = Menopause review.

[11]  S. Chakrabarti,et al.  Dopamine Cytotoxicity Involves Both Oxidative and Nonoxidative Pathways in SH-SY5Y Cells: Potential Role of Alpha-Synuclein Overexpression and Proteasomal Inhibition in the Etiopathogenesis of Parkinson's Disease , 2014, Parkinson's disease.

[12]  S. Novak,et al.  PLEIAD/SIMC1/C5orf25, a novel autolysis regulator for a skeletal-muscle-specific calpain, CAPN3, scaffolds a CAPN3 substrate, CTBP1. , 2013, Journal of molecular biology.

[13]  T. Niki,et al.  Neuroprotective Function of DJ-1 in Parkinson's Disease , 2013, Oxidative medicine and cellular longevity.

[14]  O. Hwang Role of Oxidative Stress in Parkinson's Disease , 2013, Experimental neurobiology.

[15]  S. Iguchi-Ariga,et al.  Monomer DJ-1 and Its N-Terminal Sequence Are Necessary for Mitochondrial Localization of DJ-1 Mutants , 2013, PloS one.

[16]  S. Dimauro,et al.  Human mitochondrial DNA: roles of inherited and somatic mutations , 2012, Nature Reviews Genetics.

[17]  Jianhua Zhang,et al.  Distinct Effects of Rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on Cellular Bioenergetics and Cell Death , 2012, PloS one.

[18]  Xiongwei Zhu,et al.  Parkinson’s disease‐associated DJ‐1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction , 2012, Journal of neurochemistry.

[19]  Michael R. Duchen,et al.  Mitochondria, calcium-dependent neuronal death and neurodegenerative disease , 2012, Pflügers Archiv - European Journal of Physiology.

[20]  R. Youle,et al.  Neurodegeneration: Trouble in the cell's powerhouse , 2012, Nature.

[21]  J. Cannon,et al.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  M. Duchen,et al.  Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. , 2011, Brain : a journal of neurology.

[23]  L. Chin,et al.  Parkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage. , 2010, Human molecular genetics.

[24]  R. Swerdlow,et al.  Regulation of neuron mitochondrial biogenesis and relevance to brain health. , 2010, Biochimica et biophysica acta.

[25]  P. Heutink,et al.  Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6 , 2010, Cell Death and Differentiation.

[26]  T. Gasser,et al.  DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders. , 2009, Free radical biology & medicine.

[27]  W. Wurst,et al.  Regulation of astrocyte inflammatory responses by the Parkinson's disease‐associated gene DJ–1 , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[29]  K. Doheny,et al.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease , 2009, Human Genetics.

[30]  E. Klein,et al.  Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia. , 2008, Biochimica et biophysica acta.

[31]  A. Fink,et al.  Structural impact of three Parkinsonism-associated missense mutations on human DJ-1. , 2008, Biochemistry.

[32]  M. Toledano,et al.  ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis , 2007, Nature Reviews Molecular Cell Biology.

[33]  F. Regnier,et al.  Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease. , 2007, Biochemistry.

[34]  C. Chinopoulos,et al.  Bioenergetics and the formation of mitochondrial reactive oxygen species. , 2006, Trends in pharmacological sciences.

[35]  T. Niki,et al.  Proper SUMO-1 conjugation is essential to DJ-1 to exert its full activities , 2006, Cell Death and Differentiation.

[36]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[37]  Xin Zhao,et al.  Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  David W. Miller,et al.  Effects of DJ-1 mutations and polymorphisms on protein stability and subcellular localization. , 2005, Brain research. Molecular brain research.

[39]  Andrew Lees,et al.  Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.

[40]  A. Abeliovich,et al.  DJ-1 Is a Redox-Dependent Molecular Chaperone That Inhibits α-Synuclein Aggregate Formation , 2004, PLoS biology.

[41]  Thomas Floss,et al.  Sensitivity to Oxidative Stress in DJ-1-Deficient Dopamine Neurons: An ES- Derived Cell Model of Primary Parkinsonism , 2004, PLoS biology.

[42]  T. Niki,et al.  Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. , 2004, Biochemical and biophysical research communications.

[43]  M. Owen,et al.  The GDP-GTP Exchange Factor Collybistin: An Essential Determinant of Neuronal Gephyrin Clustering , 2004, The Journal of Neuroscience.

[44]  Mark A. Wilson,et al.  The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[46]  W. Melchers,et al.  The Coxsackievirus 2B Protein Suppresses Apoptotic Host Cell Responses by Manipulating Intracellular Ca2+ Homeostasis* , 2004, Journal of Biological Chemistry.

[47]  Keith D Wilkinson,et al.  Familial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function* , 2004, Journal of Biological Chemistry.

[48]  C. Haass,et al.  Differential Effects of Parkinson's Disease-associated Mutations on Stability and Folding of DJ-1* , 2004, Journal of Biological Chemistry.

[49]  T. Niki,et al.  DJ‐1 has a role in antioxidative stress to prevent cell death , 2004, EMBO reports.

[50]  Vincenzo Bonifati,et al.  Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson’s disease , 2004, Journal of Molecular Medicine.

[51]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[52]  N. Quinn,et al.  The role of pathogenic DJ‐1 mutations in Parkinson's disease , 2003, Annals of neurology.

[53]  M. Bowman,et al.  Architecture of the Qo site of the cytochrome bc1 complex probed by superoxide production. , 2003, Biochemistry.

[54]  T. Niki,et al.  DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. , 2003, Molecular cancer research : MCR.

[55]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[56]  Hiroyoshi Ariga,et al.  DJ-1 Positively Regulates the Androgen Receptor by Impairing the Binding of PIASxα to the Receptor* , 2001, The Journal of Biological Chemistry.

[57]  Bonifati,et al.  Association between early-onset Parkinson's disease and mutations in the parkin gene. , 2000, The New England journal of medicine.

[58]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[59]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.